Feb. 1, 2019 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHAand NYSE: APHA) has completed its first transfer of plant cuttings from four of the Company's cannabis strains to Denmark-based Schroll Medical ("Schroll"), as part of the Company's previously announced Strategic Partnership (the "Partnership") with Schroll.
Read more
Aphria Introduces First Cannabis Strains to be Produced in Europe with Export to Danish Partner Schroll Medical
